Form 8-K - Current report:
SEC Accession No. 0001193125-26-147660
Filing Date
2026-04-08
Accepted
2026-04-08 16:15:18
Documents
12
Period of Report
2026-04-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d131347d8k.htm   iXBRL 8-K 31380
2 EX-99.1 d131347dex991.htm EX-99.1 118244
  Complete submission text file 0001193125-26-147660.txt   288480

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA hura-20260402.xsd EX-101.SCH 2854
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE hura-20260402_lab.xml EX-101.LAB 17992
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hura-20260402_pre.xml EX-101.PRE 11263
16 EXTRACTED XBRL INSTANCE DOCUMENT d131347d8k_htm.xml XML 3719
Mailing Address 10500 UNIVERSITY CENTER DR. SUITE 110 TAMPA FL 33612
Business Address 10500 UNIVERSITY CENTER DR. SUITE 110 TAMPA FL 33612 813-875-6600
TuHURA Biosciences, Inc./NV (Filer) CIK: 0001498382 (see all company filings)

EIN.: 990360497 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37823 | Film No.: 26848297
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)